At 15 weeks, unborn babies have a heartbeat, can sense pain, respond to physical stimulation, taste, hiccup, move around, and open and close their hands. This is the basis of the Dobbs v. Jackson case that seeks to overturn Roe v. Wade and restrict abortions after 15 weeks.
While many celebrate this provision for life, others are working diligently to implement policies to keep access to abortions readily available. Examples of Uber and Lyft covering legal fees or companies paying travel expenses for employees to get abortions have been discussed.
But one rapidly expanding loophole still lurking in the shadows is the newfound access to abortifacient drugs via direct mail that was made possible in 2021 due to telehealth extensions during the Covid-19 lockdowns.
Abortifacient drugs, mifepristone, misoprostol, and levonorgestrel, are currently authorized before a baby reaches ten weeks’ gestation. But the question that has not been answered is how a doctor can verify gestational age without seeing their patient in person or how they can provide care for health complications that may arise from the drugs. The adage, “where there is a will, there is a way,” rings true as this loophole protects the profits for drug companies and doctors from the SCOTUS ruling, enabling them to collect their dues without seeing or treating their patients.
The adage, “where there is a will, there is a way,” rings true as this loophole protects the profits for drug companies and doctors from the SCOTUS ruling, enabling them to collect their dues without seeing or treating their patients.
Sadly, we are seeing a significant shift in this direction. According to the pro-abortion Guttmacher Institute, 2020 was the first year that more than half (54%) of all abortions performed in the U.S. were done with drugs instead of instruments.
This reality is alarming, but perhaps even more disturbing is that almost every pro-life investor is profiting from these abortifacient drugs through companies they hold in their portfolios. Meaning that those who are advocating for life are unknowingly profiting from death. Let that sink in… Grieve over this, but do not despair. There is grace and mercy for our unknowing involvement. However, healthy conviction and accountability come with learning the truth, and action is needed for every Christian to remove their investments and profits from companies that are manufacturing, distributing, and financially supporting the products that are responsible for ending the lives of tens of millions of unborn children.
So, who are these companies? Meet the Abortion Drug “Dirty Dozen” companies leading the charge in manufacturing and distributing the abortifacient drugs mifepristone, misoprostol, and levonorgestrel.
We cannot allow our influential dollars to remain invested in these companies and profit from their products that end life.
It is a tragedy and horror that pro-life Christians are invested in the abortion industry. But we do not have to be. If pro-lifers want to see an end to abortion in our time, we need to put our money where our mouth is. We need to hold ourselves and our institutions accountable to keep the dollars we invest and donate out of the abortion industry and close the doors to this loophole.
Daniel received his Bachelor's in Organizational Management from The Master's University in Southern California. He has worked in business and ministry leadership for 15 years and previously served as the Executive Director for a world-class Rescue Mission in Los Angeles County.
